Study of AZLI in a CAT Regimen of Inhaled Antibiotics for Chronic Pulmonary Pseudomonas Aeruginosa


Clinical Trial

Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL

Trial Name

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection

What is the trial about?

A study in adult and pediatric subjects with Cystic Fibrosis (CF) and pulmonary Pseudomonas aeruginosa (PA) infection.

Who can participate?

Patients ≥6 years of age with Cystic Fibrosis.

What is involved?

Length of study is 6 months. Tests include blood draws, bronchodilator, and spirometry.

Contact Nemours Clinical Trials

Trial Name: A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas Aeruginosa Infection

Contact Information

(800) 354-5690
clinicaltrials@nemours.org